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Cryptococcus neoformans, which causes fatal infection in immunocompromised individuals, has an elaborate polysac-
charide capsule surrounding its cell wall. The cryptococcal capsule is the major virulence factor of this fungal organism,
but its biosynthetic pathways are virtually unknown. Extracellular polysaccharides of eukaryotes may be made at the cell
membrane or within the secretory pathway. To test these possibilities for cryptococcal capsule synthesis, we generated a
secretion mutant in C. neoformans by mutating a Sec4/Rab8 GTPase homolog. At a restrictive temperature, the mutant
displayed reduced growth and protein secretion, and accumulated100-nm vesicles in a polarized manner. These vesicles
were not endocytic, as shown by their continued accumulation in the absence of polymerized actin, and could be labeled
with anti-capsular antibodies as visualized by immunoelectron microscopy. These results indicate that glucuronoxylo-
mannan, the major cryptococcal capsule polysaccharide, is trafficked within post-Golgi secretory vesicles. This strongly
supports the conclusion that cryptococcal capsule is synthesized intracellularly and secreted via exocytosis.
INTRODUCTION
Naturally occurring glycoconjugates are incredibly diverse and
are generally found outside of cells. In bacteria, these molecules
include peptidoglycan, lipopolysaccharides (LPS), and capsu-
lar polysaccharides. These compounds are synthesized on ei-
ther peptide (peptidoglycans) or lipid (LPS and capsular poly-
saccharides) primers by bacterial glycosyltransferases. These
enzymes are usually localized in the membrane, thereby cou-
pling the synthesis and export of extracellular polysaccharides
(van Heijenoort, 2001; Raetz and Whitfield, 2002; Whitfield,
2006).
In fungi, most of the cell wall is composed of polysaccha-
rides, including - and/or -glucans, chitin, and some man-
nans (Bose et al., 2003; Latge et al., 2005; Klis et al., 2006;
Lesage and Bussey, 2006; Ruiz-Herrera et al., 2006). Glucans
and chitin are polymers of glucose and N-acetylglucosamine
(GlcNAc), respectively, and the corresponding synthases are
thought to function at the plasma membrane (Leal-Morales
et al., 1988; Cortes et al., 2002; Konomi et al., 2003; Valdivia
and Schekman, 2003; Ortiz and Novick, 2006). It is unclear
how synthesis of these polymers is initiated. Mannans are
highly branched mannose polymers (100–300 mannoses in
Saccharomyces cerevisiae) that are assembled in the secretory
pathway as components of protein N-glycan moieties (Dean,
1999; Munro, 2001). The polypeptides that will bear mannan
are synthesized in the endoplasmic reticulum (ER) and re-
ceive core N-glycans before moving to the Golgi apparatus.
There they encounter glycosyltransferases that extend the
N-glycan chains, and the completed mannan-bearing pro-
teins progress to the cell surface.
The major cell wall component of plants is cellulose, an
-1,4–linked glucose polymer. Like fungal wall components,
it is made at the cell surface (Somerville, 2006). Two other
categories of plant cell wall polymers are pectin and hemi-
cellulose, which provide rigidity and flexibility to the cell
wall by interconnecting cellulose fibers (Reiter, 2002;
Scheible and Pauly, 2004). These complex polymers are
made in the secretory pathway, but elucidating their biosyn-
thetic pathways has been extremely challenging (Dhugga,
2005; Bacic, 2006).
In animals, most cell-associated extracellular glycoconju-
gates are protein- or lipid- linked molecules that are made in
the secretory pathway and displayed on the cell surface. One
exception is hyaluronan, a linear polymer of disaccharide
units of glucuronic acid and GlcNAc, which is synthesized
at the plasma membrane (Weigel et al., 1997; Itano and
Kimata, 2002). In general, therefore, extracellular polysac-
charide synthesis in eukaryotic cells occurs either at the cell
membrane, as in bacteria, or in the secretory pathway.
We are interested in the synthesis of polysaccharide mol-
ecules on the surface of Cryptococcus neoformans. C. neofor-
mans is an environmental basidiomycetous yeast that causes
fatal infections in mammals. The two most widespread se-
rotypes, A and D, are a leading cause of fungal meningoen-
cephalitis in immunocompromised individuals, with the
majority of cases caused by serotype A strains. The charac-
teristic of C. neoformans that is unique among pathogenic
fungi is the polysaccharide capsule that surrounds its cell
wall (Bose et al., 2003; Janbon, 2004). Similar to bacterial
capsules, the cryptococcal capsule is important for immune
evasion in the host (Kozel and Gotschlich, 1982; Vecchiarelli,
2005), but its composition and structure differ greatly from
its bacterial counterparts. The cryptococcal capsule consists
mainly of two polysaccharide species, glucuronoxyloman-
nan (GXM) and galactoxylomannan (GalXM). GXM is a
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1.7-7-MDa polymer (McFadden et al., 2006) composed of
-1,3-linked mannose which is O-acetylated and substituted
with xylose and glucuronic acid residues (Cherniak and
Sundstrom, 1994). GalXM is more complex, with an -1,6-
galactan backbone and xylosylated side chains of mannose
and galactose (Vaishnav et al., 1998). GXM comprises 90%
of the capsule mass and is considered to be the major viru-
lence factor of C. neoformans. Strains lacking GXM are avir-
ulent in animal models (Chang and Kwon-Chung, 1994,
1998, 1999; Chang et al., 1996), and GXM itself has immuno-
suppressive effects (Monari et al., 2006). A critical question
about capsule polymers is how and where they are synthe-
sized. The complex structures of GXM and GalXM suggest
they might be made in the secretory pathway. On the other
hand, the strong precedent from other extracellular poly-
mers outlined above suggests they might be synthesized at
the cell membrane.
A location for capsule synthesis was first hypothesized in
1967, when Edwards et al. (1967) observed a halo between
the cell wall and the capsule using conventional transmis-
sion electron microscopy (TEM) and suggested it was a
“zone of capsule synthesis.” Several years later, Takeo et al.
(1973a, 1973b) demonstrated that this halo corresponded to
a layer of 20-nm “granules,” which they speculated were
involved in polymerization of capsule precursors. These
investigators used a freeze-etching technique to compare C.
neoformans grown in vitro to cells grown in a mouse model
of infection, which have more extensive capsule. They noted
that the number of intracellular vesicles in the latter cells
was greater and hypothesized that the capsule was synthe-
sized inside these vesicles. In both cell populations they also
observed unusual plasma membrane invaginations contain-
ing small vesicles, which they termed the “baglike paramu-
ral bodies.” This observation led them to alternatively spec-
ulate that capsule was made in the vesicles of the paramural
body.
Twenty years later, Sakaguchi et al. (1993) used the quick-
freeze, deep-etch technique to improve image resolution in
the comparison of in vivo- and in vitro-grown C. neoformans
cells and observed that a “particle-accumulating layer” be-
tween the cell wall and the capsule was thicker in cells
grown in vivo. They proposed that the accumulated parti-
cles represented capsule precursors that were then polymer-
ized into fibrils, but did not indicate a model for overall
capsule synthesis. More recently, two other reports touched
on the location of capsule synthesis in C. neoformans. As part
of a morphological study of cryptococcal cells during the
course of mouse infection, Feldmesser et al. (2001) per-
formed immunoelectron microscopy (immuno-EM) using
anti-GXM antibodies, biotin-conjugated secondary antibod-
ies, and gold-conjugated streptavidin and observed 200–
300-nm aggregations of label within the cytosol, which they
termed “vacuolar structures.” In another report, this group
used the same immuno-EM method and noted “clusters” of
gold particles in the cytoplasm and cell wall of C. neoformans
(Garcia-Rivera et al., 2004).
The reports summarized above differ in the proposed
location of capsule synthesis, with some investigators sug-
gesting it happens inside the cell and others suggesting this
process occurs outside the cell wall. They also propose that
a variety of structures are involved with capsule synthesis,
ranging from intracellular vacuoles, vesicles, or paramural
bodies to extracellular particles. We sought to definitively
address these fundamental questions of capsule synthesis,
by testing the hypothesis that the major capsular polysac-
charide, GXM, is made within the cell and secreted via
exocytosis.
Secretion is a highly conserved biological pathway that has
been well studied in the model yeast S. cerevisiae. Pioneering
work by Schekman and colleagues identified multiple yeast
genes involved in secretion (Novick and Schekman, 1979;
Novick et al., 1980), which are now known to have homologues
in other eukaryotic systems. Secretion mutants in other fungal
species have been generated, typically by mutating highly con-
served small GTPases (Craighead et al., 1993; Mao et al., 1999;
Lee et al., 2001; Punt et al., 2001; Liu et al., 2005; Siriputthaiwan
et al., 2005). One such protein is Sec4p, which regulates exocy-
tosis (Guo et al., 1999). In S. cerevisiae exocytosis mutants, ves-
icles of 100 nm in diameter accumulate upon shift to a re-
strictive temperature, and these “post-Golgi” vesicles have
been shown to contain secreted proteins (Novick et al., 1980;
Holcomb et al., 1987; Harsay and Bretscher, 1995). In this study,
we mutated a C. neoformans Sec4p homolog to address whether
GXM uses the secretory pathway to exit the cell.
MATERIALS AND METHODS
Strains and Growth Conditions
C. neoformans strains stored in 25% glycerol at80°C were streaked onto yeast
extract peptone dextrose (YPD) plates for growth at room temperature (RT) or
at 30°C. Where indicated, plates were supplemented with nourseothricin (100
g/ml) or G418 (100 g/ml). Liquid cultures were grown in YPD medium
with shaking (230 rpm) at RT or at 30°C. Serotype A strain H99 was provided
by G. Cox (Duke University) and serotype D strain JEC21 was from J. Lodge
(St. Louis University). Generation of other C. neoformans strains is described
below.
Identification of a Cryptococcal Homolog of the
Sec4/Rab8 Subfamily of Rab GTPases
BLAST was used to query the Institute of Genome Research (TIGR) annota-
tions of the C. neoformans serotype D strain JEC21 (http://www.tigr.org/tdb/
e2k1/cna1/) with the amino acid sequence of S. cerevisiae Sec4p (NP_116650).
The closest homolog (E-value of 6  1061) was CNC04340 (GenBank
XP_569689), which showed 53% identity and 67% similarity to Sec4p when
whole sequences were compared using AlignX (VectorNTI Suite, Invitrogen,
Carlsbad, CA). The genomic sequence of XP_569689, termed SAV1, was then
used to identify the corresponding locus in the serotype A strain H99 se-
quence in the Broad Institute C. neoformans database (http://www.broad.mit.
edu/annotation/genome/cryptococcus_neoformans/Home.html); this was
identified as Supercontig 5: 681180–681966. The amino acid sequence en-
coded by this serotype A protein predicted by TWINSCAN (Tenney et al.,
2004; protein 57_15; http://genome.slu.edu/) was shown to be identical to
that predicted for serotype D Sav1p.
Plasmid Construction
To clone the complete SAV1 gene with its untranslated regions (UTRs), we
PCR-amplified H99 genomic DNA (prepared as in Nelson et al., 2001) with
primers AYP72 and AYP73 (Table 1). The resulting fragment, consisting of
SAV1 with 1 kb of 5UTR and 1.5 kb of 3UTR sequence, was cloned into the
pCR2.1-TOPO plasmid (Invitrogen) to form pAY19. SAV1 was sequenced to
ensure that no errors were introduced during PCR. To obtain the desired
Val23Asn mutation, we performed PCR-based site-directed mutagenesis of
pAY19 using a QuikChange kit (Stratagene, La Jolla, CA) with primers AYP78
and AYP79. This mutated plasmid was confirmed by sequencing and termed
pAY20.
For the next step, we used a modified form of pGMC200 (McDade and Cox,
2001). pGMC200, provided by G. Cox, contains a nourseothricin acetyl trans-
ferase cassette (NAT) for drug selection in C. neoformans. The modified form
of pGMC200, termed pGMC200-MCS, contains an additional multiple cloning
site upstream of the actin promoter of NAT (H. Liu and T. L. Doering,
unpublished results). We inserted the 2.7-kb BamHI fragment of pAY20 into
a BglII-digested pGMC200-MCS. The resulting plasmid, pAY25, contains 1 kb
of the 5UTR, the sav1 gene bearing a mutation encoding the desired
Val23Asn amino acid change, and 0.5 kb of the SAV1 3UTR, inserted up-
stream of NAT. pAY25 was next modified by insertion of an additional 1 kb
of the 3UTR of SAV1 (excised from pAY20 with BamHI and XbaI; the
unlabeled gray region in Figure 1) downstream of NAT to form pAY30
(Figure 1). Finally, we replaced the pAY30 segment consisting of the mutated
sav1 sequence followed by NAT with the wild-type SAV1 gene in tandem
with a neomycin-resistant cassette (Neo) from plasmid pMH12-T (provided
by J. Lodge). The resulting plasmid was termed pAY51 (Figure 1). The same
constructs were made for the serotype D strains using sequences obtained
from JEC21 genomic DNA. Additional cloning details are available from the
authors.
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Generation of C. neoformans Strains
To replace the chromosomal SAV1 gene with a mutated copy, strain H99 was
subjected to biolistic transformation (Toffaletti et al., 1993) with linearized
pAY30, allowed to recover on YPD plates at RT for 24 h, replated onto
nourseothricin/YPD plates, and incubated at RT until colonies appeared.
Genomic DNA from 48 colonies was screened for the integration of NAT by
PCR with primers shown in Table 1: AYP30 and AYP108 for confirmation of
downstream integration and AYP31 and AYP109 for upstream integration. A
SAV1 gene fragment spanning the mutation was sequenced from all 10
colonies with correctly integrated NAT, and two strains, one with the desired
mutation (GTG to AAC) and one with wild-type sequence, were chosen for
study. The former strain was termed sav1, and the latter strain (a matched
wild-type control with NAT inserted at the same genomic site) was termed
SAV1 (see Figure 1).
To restore wild-type SAV1, the sav1 strain was biolistically transformed
with BstXI-digested pAY51. Transformants were allowed to recover as above,
replated onto G418-containing YPD plates to select for cells harboring Neo,
and incubated at 30°C. They were then screened for loss of nourseothricin
resistance, as well as for the ability to grow at 37°C (see Results). SAV1 and
sav1 strains were confirmed to have the single desired insertion in the genome
by DNA blotting (unpublished data). A set of serotype D strains was similarly
generated from the parent strain JEC21, except that sav1 candidate colonies
were screened for lethality at 37°C and for morphological change and dull
appearance of colonies at 30°C before PCR, sequencing, and DNA blotting for
confirmation (unpublished data). The sav1::SAV1 strain was generated by
biolistic cotransformation (Goins et al., 2006) of the sav1 strain with two DNA
fragments: one with the wild-type SAV1 with 5 and 3 1-kb flanking se-
quences and the other containing Neo. PCR and DNA blotting showed that
this strain contains one replacement at the desired genomic site and one
additional ectopic insertion of Neo (unpublished data).
Electron Microscopy
Strains were grown in 50 ml of YPD medium at RT overnight, diluted to 2 
106 cells/ml in fresh YPD medium, and grown at RT for 6 h. The cultures were
divided into two flasks and grown at RT or at 30°C with shaking for 3 h. The
cultures were then centrifuged in 50-ml conical tubes, the medium was
discarded, and the cell pellets were quickly resuspended in 1 ml of primary
fixation mix (0.1 M sorbitol, 1 mM MgCl2, 1 mM CaCl2, 2% glutaraldehyde in
0.1 M PIPES buffer, pH 6.8; Wright, 2000). The cell suspension was transferred
into 1.5-ml microcentrifuge tubes and sedimented in a tabletop microcentri-
fuge (0.5 min, RT, top speed). Cell pellets were resuspended in 1 ml of
primary fixation mix and fixed overnight at 4°C.
For optimal visualization of membrane structure, cells were postfixed with
potassium permanganate. Cells were sedimented and washed three times in
water (each wash involved resuspension of the pellet followed by a 10-min
incubation at RT) and transferred into 13  100 mm borosilicate glass tubes
(Fisher Scientific, Pittsburgh, PA). Cells were again sedimented to remove
water and resuspended in 2% KMnO4 aqueous solution. The final centrifu-
gation and resuspension steps were repeated, and the cells were postfixed for
45 min and then washed in water as above until a purple color was no longer
visible. Cells were next transferred to microcentrifuge tubes and dehydrated
by successive 10-min incubations in water–ethanol mixtures with increasing
ethanol concentrations. The ethanol-substituted samples were then substi-
tuted in propylene oxide (twice for 30 min each) and infiltrated and embed-
ded in Eponate 12 resin (Ted Pella, Redding, CA). Blocks were polymerized
for at least 24 h at 65°C. The samples were cut into 60–80-nm sections with a
Leica Ultracut UCT ultramicrotome (Leica Microsystems, Bannockburn, IL)
and were viewed with a JEM 1200EX transmission electron microscope (JEOL
USA, Peabody, MA) after uranyl acetate-lead citrate staining.
For immuno-EM, cells were fixed in glutaraldehyde as above, washed in 50
mM citrate buffer, pH 6.0, three times, and resuspended in 1 ml of 40 mg/ml
Lysing enzymes (L1412, Sigma, St. Louis, MO) in the same buffer. After 30
min of partial cell wall digestion at 30°C, cells were washed in 0.1 M phos-
phate buffer, pH 7.0, three times and postfixed in 1% OsO4 in the same buffer
for 1 h at RT. Blocks were prepared as described above. Sections were blocked
with a solution of 5% FBS in 100 mM PIPES buffer (pH 7.0) for 30 min, labeled
with an anti-GXM mAb (either 3C2 from T. Kozel, University of Nevada at
Reno, or 2H1 from A. Casadevall, Albert Einstein College of Medicine) for 1 h,
washed in blocking buffer, and incubated with 12-nm gold-conjugated goat
anti-mouse IgG antibody (Jackson ImmunoResearch, West Grove, PA). Sec-
tions were then washed once in 100 mM PIPES buffer, pH 7.0, and twice in
water, stained with uranyl acetate and lead citrate, and viewed as above.
Acid Phosphatase Secretion Assay
Acid phosphatase secretion was assayed using intact cells (To-e et al., 1973).
Overnight cultures of C. neoformans strains grown at RT in a minimal medium
supplemented with phosphate (0.5% KH2PO4; Cerda´-Olmedo and Lipson,
1987) were washed in a minimal medium without phosphate (0.5% KCl
instead of KH2PO4) and resuspended in 25 ml of the same medium at 1  107
cells/ml. From this, 12.5 ml was then incubated with shaking either at RT or
at 30°C. After 6 h of incubation, the cells from 1-ml aliquots of the cultures
were harvested, resuspended in 400 l of substrate buffer (2.5 mM para-
nitrophenylphosphate in 50 mM acetate buffer, pH 4.0), and incubated at 37°C
for 5 min. The reactions were stopped by adding 800 l of saturated Na2CO3,
and absorbance was read in a spectrophotometer. The difference in A420
Table 1. Primers used for PCR in this study
Primer name Sequence (5-3)
Cloning of SAV1 with UTRs
AYP72 GCATCGACAATACC TGCAAGCTCATCATCG
AYP73 CCTACTGCCCAGGAATTCCTCTTGACC
Site-directed mutagenesis of SAV1
AYP78 GCAACTCTTGATAGGT AAC GGCAAGTCATGTCTCCTCTTGC
AYP79 GCAAGAGGAGACATGACTTGCC GTT ACCTATCAAGAGTTGC
Confirmation of downstream integration
AYP30 CGAATCCGAGACAGACAT
AYP108 CGTCTCTCATATGCTGCAGC
Confirmation of upstream integration
AYP31 CTGCATGCTTATGTGAGTCC
AYP109 CCGTCTTGTTA GCTCCAAGG
Bold residues indicate the engineered mutation in SAV1 (see text).
Figure 1. Chromosomal position of the SAV1 gene and drug mark-
ers in the cryptococcal strains used in this work. H99, the serotype
A parent strain; SAV1, a nourseothricin-resistant wild-type control
strain; sav1, the sav1 mutant strain with the same marker;
sav1::SAV1, a restored strain in which sav1 has been replaced with
the wild-type SAV1 gene and the NAT marker with Neo. The drug
resistance cassettes were inserted 0.5 kb downstream of the SAV1
stop codon in each case, and each construct used for biolistic trans-
formation contained 1-kb flanking regions for homologous recom-
bination. The asterisk in sav1 indicates the position of the sequence
encoding the Val23Asn mutation. The gray region 3 to the labeled
genes designates corresponding regions of the 3UTR. Plasmid des-
ignations in parentheses refer to constructs described in Materials
and Methods.
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between the final cell suspension and a blank reaction without cells was
calculated, and results were normalized by cell density (A600).
Statistics
Statistical significance was assessed with Microsoft Excel X for Mac (Red-
mond, WA) using either Student’s t test, to compare pairs of samples, or
z-test, for comparison to the normalized wild-type value of 100 in acid
phosphatase assays.
RESULTS
Sav1p Is A Cryptococcal Homolog of the Sec4/Rab8
Subfamily of Rab GTPases
To generate a late secretion mutant in C. neoformans, we
targeted a homolog of Sec4p. Sec4p is a small GTPase of the
Rab subfamily that acts as a “master regulator” of exocytosis
(Novick and Zerial, 1997; Guo et al., 1999; Segev, 2001), and
conditional sec4 mutants in S. cerevisiae accumulate post-
Golgi vesicles under restrictive conditions (Novick et al.,
1980; Mulholland et al., 1997). We find at least seven Rab
GTPases in C. neoformans, using the Institute of Genome
Research (TIGR) annotations of the C. neoformans serotype D
strain JEC21 (http://www.tigr.org/tdb/e2k1/cna1/) and
TWINSCAN (Tenney et al., 2004) predicted proteins of sero-
type A strain H99 (http://genome.slu.edu/). The two of
these that are closest to the S. cerevisiae Sec4p sequence,
XP_568088 and XP_569689, are very similar (54% identity
and 70% similarity). However, we noted that the former
contains a Ypt1/Rab1-specific stretch of sequence (amino
acids 33–44), whereas the latter contains Sec4/Rab8-specific
sequence (amino acids 39–44) (Nussbaum and Collins,
2005). This indicated that XP_569689 is a member of the
Sec4/Rab8 subfamily. We termed this gene SAV1, because
cells with a mutant copy were secretion-deficient and accu-
mulated vesicles (see below).
Extending the homology to Sec4-related proteins, Sav1p is
closely related to the Colletotrichum lindemuthianum Clpt1p
(Dumas et al., 2001; Siriputthaiwan et al., 2005; 72% identity,
79% similarity), which was identified as a filamentous fun-
gal homolog of Sec4p. Notably, like the Schizosaccharomyces
pombe Sec4p homolog Ypt2p (Haubruck et al., 1990), Sav1p is
more closely related to the higher eukaryotic Rab8 (58%
identity and 71% similarity to human Rab8) than to the S.
cerevisiae Sec4p. The sequences of these proteins and other
fungal homologues are shown in Figure 2. Ypt2p and Clpt1p
were both able to complement a temperature-sensitive mu-
tant of SEC4 in S. cerevisiae, sec4-8 (Haubruck et al., 1990;
Dumas et al., 2001), although the Aspergillus niger homolog,
SrgAp, was not (Punt et al., 2001). Expression of the crypto-
coccal homolog, Sav1p, also did not complement sec4-8
(Supplementary Figure S1).
Because secretion is an essential process and there is only
one homolog of Sec4p in C. neoformans (Sav1p), we sought to
generate a conditional mutant of SAV1. In S. pombe, muta-
tion of a conserved Val residue within the first GTP-binding
domain of Ypt2p (Figure 2, arrow) produced a temperature-
sensitive mutant (Craighead et al., 1993). We adopted this
strategy to obtain a temperature-sensitive mutant of Sav1p,
using site-directed mutagenesis to generate a mutation en-
coding the same Val-to-Asn change in the G1 region of
SAV1. The mutated gene, in tandem with a drug resistance
marker and flanked by endogenous UTR sequences, was
introduced into serotype A C. neoformans strain H99 by
biolistic transformation. Alternate cross-over events yielded
both the desired mutant (sav1) and a matched drug-resistant
control strain (SAV1), as shown in Figure 1 and detailed in
the Materials and Methods. We also generated a strain in
which sav1 was restored to wild type by replacement of the
mutated gene, termed sav1::SAV1 (Figure 1).
The sav1 Mutation Confers Temperature-sensitive Growth
and Defective Protein Secretion
Once sav1 and control strains were generated, we tested
whether the Val23Asn mutation indeed conferred the ex-
pected temperature-sensitive growth phenotype. As shown
in Figure 3, sav1 showed no growth defect as compared with
the SAV1 and sav1::SAV1 strains at RT, but grew more
slowly at 30°C. Furthermore, 37°C was completely lethal to
the sav1 mutant, which under these conditions displayed
massive cell wall damage (unpublished data). For further
studies we chose the semipermissive temperature of 30°C,
where cell growth was impaired but cell wall damage was
minimal.
The originally generated strains were of serotype A. To
assess consistency of the sav1 phenotype, we generated a
parallel set of strains in a serotype D background. The
serotype D sav1 mutant was even more sensitive to high
temperatures, exhibiting a slight growth defect at RT and
very slow growth at 30°C (Supplementary Figure S2).
Next, we tested whether Sav1p is involved in protein
secretion. The invertase assay, a commonly used secretion
assay for S. cerevisiae, was not suitable for C. neoformans
(unpublished data), probably because of the difficulty of
generating protoplasts in this organism. We instead used an
assay for acid phosphatase secretion (van Rijn et al., 1972;
Figure 2. Sequence comparison of selected Sec4p homologues. Cn, C. neoformans Sav1p; Sp, S. pombe Ypt2p; Cl, C. lindemuthianum Clpt1p;
An, Aspergillus niger SrgAp; Hs, Homo sapiens Rab8p; Sc, S. cerevisiae Sec4p. Residues that are identical in all sequences are shaded black; those
conserved in four or five of six sequences are in gray. G1–G5 indicate conserved GTP binding domains, the vertical arrow indicates the
conserved Val residue that was mutagenized to Asn in S. pombe (Craighead et al., 1993), and a conserved prenylation site at the C-terminus
is marked with asterisks.
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To-e et al., 1973; Novick and Schekman, 1979). This assay
takes advantage of the localization of secreted acid phospha-
tase: this enzyme is retained in the cell wall after secretion,
where it can act on an exogenously supplied colorimetric
substrate. As shown in Figure 4, sav1 cells displayed a sig-
nificant protein secretion defect both at RT and 30°C. The
sav1::SAV1 strain secreted a normal level of acid phospha-
tase at both temperatures, confirming that the observed
secretion defect is due to the mutation in SAV1. This result
suggests that Sav1p is required for protein secretion, like
other Sec4/Rab8 GTPases.
The sav1 Mutant Exhibits Separation Defects and
Accumulates Vesicles at the Septum and the Bud
Defects in exocytosis often lead to alterations in morphol-
ogy. We observed that when sav1 cells were grown at 30°C
for more than 6 h, budding cells with abnormally thick necks
(Figure 5A) became prevalent. This phenotype was reminis-
cent of S. pombe, where exocytosis mutants exhibit cell sep-
aration defects due to their inability to properly localize
enzymes required to digest septa (Wang et al., 2002; Martin-
Cuadrado et al., 2005). We suspected that this was also
occurring in the cryptococcal sav1 cells and examined their
morphology more closely by TEM. The preparation method
we used (with KMnO4, see Materials and Methods) does not
preserve capsule but is excellent for visualizing membrane
structures and cell walls. These studies revealed abnormally
wide and thick septa in dividing sav1 cells, with accumula-
tion of 100-nm vesicles at the septum (Figure 5B). Cells
undergoing septation were rarely observed in wild-type C.
neoformans in the growth conditions used; cells were either
engaged in budding or had already separated.
The classic manifestation of exocytic defects in budding
yeast is accumulation of post-Golgi vesicles, particularly in
the growing bud itself (Novick and Schekman, 1979). When
sav1 cells were shifted to the restrictive temperature of 30°C
for 3 h, we observed striking accumulation of vesicles at the
bud (Figure 6). This phenotype was absent in the two control
strains and was enhanced with increased time at 30°C (Fig-
Figure 4. The sav1 mutation results in decreased acid phosphatase
secretion. Acid phosphatase secretion was induced by depletion of
phosphate as described in Materials and Methods and is shown
corrected for cell density and normalized to wild-type levels. ,
SAV1; f, sav1; u, sav1::SAV1; all strains are serotype A. The mean
and SE values plotted were compiled from seven independent
experiments performed in duplicate for the SAV1 and sav1 strains,
and four independent experiments performed in duplicate for the
sav1::SAV1 strain. Statistically significant differences were observed
between the sav1 mutant and wild-type strains (p  0.001 at both
temperatures) and between the sav1 mutant and complemented
strains (p 0.003 at RT; p 0.001 at 30°C). There was no significant
difference between wild-type and complemented strains (p  0.19
for RT; p  0.21 for 30°C).
Figure 5. sav1 exhibits a cell separation defect at 30°C. (A) Light
micrographs of serotype A SAV1, sav1, and sav1::SAV1 strains
grown in YPD for 10 h at 30°C. Scale bar, 5 m. (B) Electron
micrograph of a sav1 cell grown in the same way, showing an
undigested septum and accumulation of 100-nm vesicles. Sp, sep-
tum; Ves or arrowheads, vesicles; Mt, mitochondria; CW, cell wall.
Scale bar, 0.5 m.
Figure 3. sav1 displays temperature sensitivity at 30°C. SAV1,
sav1, and sav1::SAV1 strains grown on YPD plates at RT were
suspended in sterile water and diluted to 6  105 cells/ml, and
serial fivefold dilutions were spotted onto YPD plates. Plates were
incubated at the indicated temperatures for 3 d.
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ure 6). The accumulated vesicles were 100 nm in size,
consistent with their identification as post-Golgi secretory
vesicles.
We observe more vesicles in the serotype D wild-type
strain JEC21 than in the serotype A wild-type strain H99.
The sav1 mutation in a JEC21 background also resulted in
more extensive accumulation of vesicles at 30°C in a shorter
period (unpublished data), consistent with our preliminary
observation that protein secretion is more active in serotype
D (Supplementary Figure S3).
Because of the homology between Sec4p and Sav1p, and
the morphological and secretion defects observed, we be-
lieve the vesicles that accumulate in sav1 cells are exocytic.
However, we tested the formal possibility that these vesicles
could be endocytic, by using the actin-depolymerizing drug,
latrunculin B (LatB). Endocytosis is inhibited when cells are
treated with actin-depolymerizing drugs, because internaliza-
tion of endocytic vesicles requires actin patches (Ayscough,
2000, 2005; Huckaba et al., 2004; Kaksonen et al., 2005). In
contrast, such drugs should not interfere with generation of
secretory vesicles, although it will affect their polarization
because this process depends on F-actin cables (Karpova et
al., 2000). We therefore expected that cells grown with LatB
should lack endocytic vesicles, but would generate post-
Golgi vesicles that become dispersed throughout the cell.
When C. neoformans strains were treated with 400 M LatB,
no F-actin structures were detected (Supplementary Figure
S4). Despite this perturbation, there was no change in the
total accumulation of 100-nm vesicles in sav1 cells. This
remained at a level of fourfold over wild type (vesicles per
EM section), with or without LatB (Figure 7). The LatB
vesicles, however, were no longer polarized (Figure 7; elec-
tron micrograph in Supplementary Figure S5).
The Accumulated Vesicles in sav1 Contain GXM
Previous studies of C. neoformans have shown that the cap-
sule enveloping daughter cells consists of newly synthesized
material (Pierini and Doering, 2001; Zaragoza et al., 2006). If
this material is synthesized intracellularly and exits via the
secretory pathway, we expect to detect GXM in the post-
Golgi vesicles that accumulate in sav1 buds under restrictive
conditions. To test this, we used anti-GXM antibodies and
immuno-EM. The EM method used above (Figures 5 and 6)
is not suitable for immuno-EM, because the strong oxidizing
reagent used in the preparation does not preserve the anti-
genicity of carbohydrates, specifically capsule in this case.
Further, en bloc staining with uranyl acetate alters the ul-
trastructure of the capsule (A. Yoneda and T. L. Doering,
unpublished observation). To avoid these technical prob-
lems, we instead prepared samples using glutaraldehyde
and osmium tetroxide fixations followed by embedding in
plastic resin (Materials and Methods), and then performed
immuno-EM using two independently derived anti-GXM
monoclonal antibodies and gold-conjugated secondary anti-
body. In both SAV1 and sav1::SAV1 cells, the extracellular
capsule was abundantly labeled with gold particles, whereas
there were only a few gold particles visible within the cell.
Although extracellular capsule was also labeled in sav1 cells
grown at 30°C for 3 h, significant numbers of gold particles
were visible inside the cell, and the majority of them were
observed within vesicles (Figure 8).
The buds of sav1 cells grown at 30°C do bear newly
synthesized cell wall and capsule material (unpublished
data; studies performed as in Pierini and Doering, 2001), due
to the incomplete nature of the secretory block. This indi-
cates that no unusual capsule rearrangement occurs under
these conditions.
DISCUSSION
Understanding the synthesis of extracellular glycoconju-
gates poses unique challenges. Unlike polymerization of
other cellular macromolecules, there are few “rules” govern-
ing the initiation of glycan synthesis, where this synthesis
occurs, or how the products associate with the cell. In this
Figure 6. Vesicles accumulate in the bud of sav1 cells. 3 h after
temperature shift to 30°C, putative post-Golgi vesicles are accumu-
lated in the bud of sav1 cells, but not in SAV1 or sav1::SAV1. All
strains are serotype A. This vesicle accumulation becomes more
dramatic upon longer incubation (10 h, right lower panel). Scale bar,
0.4 m.
Figure 7. sav1 cells contain more total vesicles than SAV1 cells,
with or without latrunculin B (LatB), but in LatB conditions the
vesicles are no longer polarized to the bud. For each strain, cells
were shifted to 30°C for 3 h concurrent with LatB or ethanol (con-
trol) treatment and examined by EM. Vesicles present in sections of
60 budding cells were counted, and the average numbers of vesicles
per section in the mother and bud were plotted. u, vesicles in a
mother cell; f, vesicles in a bud/daughter cell. Mean and SE are
plotted. The fraction of vesicles observed in the bud decreased
significantly in each strain upon LatB treatment [45.6 to 33.6% (p 
0.02) for SAV1; 66.2 to 28.8% (p  0.001 for sav1 cells)].
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study, we have addressed a long-standing question regard-
ing the location of synthesis and mechanism of export of
GXM, the major capsule polysaccharide of C. neoformans.
Early studies in C. neoformans suggested either intracellu-
lar or cell surface synthesis of capsule, but settling this
question has remained elusive (Edwards et al., 1967; Takeo et
al., 1973a, 1973b; Sakaguchi et al., 1993; Feldmesser et al.,
2001; Garcia-Rivera et al., 2004). The major conclusion from
our study is that GXM is trafficked within secretory vesicles,
supporting a model that capsular materials are synthesized
in the Golgi and targeted to the plasma membrane for exo-
cytosis. Although our experiments do not distinguish be-
tween direct movement of GXM-containing post-Golgi ves-
icles to the plasma membrane and movement to that site via
recycling endosomes (Gurunathan et al., 2002; Harsay and
Schekman, 2002; Ang et al., 2004), they clearly indicate that
capsule synthesis is intracellular.
Our studies used anti-GXM monoclonal antibodies to
probe vesicle contents. They do not directly address the
biosynthesis of the second capsule polysaccharide, GalXM,
although we speculate that this polymer is similarly made in
the secretory pathway. To prove this would require either
antibodies of appropriate specificity or the identification of
enzymes involved in GalXM synthesis, which could then be
Figure 8. savl cells accumulate
vesicles that contain GXM. Strains
were grown in YPD at RT for 6 h
and then shifted to 30°C for 3 h
(for serotype A strains) or for
1.5 h (for serotype D strains). Ul-
trathin sections were labeled with
the anti-GXM mAb 3C2 and
12-nm gold-conjugated anti-
mouse antibody as described in
Materials and Methods, and images
of buds are shown. Similar results
were obtained using the anti-
GXM mAb 2H1 (unpublished
data). (A) Serotype A strains;
scale bar, 0.4 m. (B) The serotype
D sav1 strain; scale bar, 0.2 m.
Arrowheads, labeled vesicles;
Cap, capsule; other abbreviations
as in Figure 5. Note that when
100-nm vesicles are cut into
80-nm sections, in many cases
only part of the vesicle is visible.
Such portions may appear as
small areas devoid of ribosomes,
but may still be labeled with anti-
GXM antibodies.
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localized within the cell. These studies must therefore await
the development of such reagents.
The primary GXM-containing structures we observed
were secretory vesicles. In early ultrastructural studies,
Takeo et al. (Takeo et al., 1973a, 1973b) hypothesized that
30–70-nm intracellular vesicles and/or 50-nm vesicles in
paramural bodies were involved in capsule synthesis. The
typical intracellular vesicle size we observed was 100 nm,
although it ranged from 60 to 130 nm (Figures 6 and 8). This
difference could be due to sample preparation, because the
previous study used a freeze-etching technique, and we
used plastic embedding and thin-sectioning. It is also pos-
sible that the previously observed small (30–50 nm) vesicles
were endocytic (Prescianotto-Baschong and Riezman, 1998),
in contrast to those that we observed. Structures similar to the
paramural body are occasionally observed in C. neoformans
strains grown in vitro (A. Yoneda and T. L. Doering, unpub-
lished TEM observation), although their significance is not
known. They could potentially be related to mammalian
exosomes (Thery et al., 2002) or plant paramural bodies (An
et al., 2006).
In more recent studies using anti-GXM antibodies,
Feldmesser et al. (2001) showed immuno-gold labeling of
200–300-nm electron-lucent areas in the cytosol, and Garcia-
Riviera et al. (2004) noted “clusters” of antibody labeling in
the cytosol and in the cell wall. The size of the former entities
and cell wall location of the latter suggest these do not
correspond to post-Golgi vesicles.
In other ultrastructural studies, Sakaguchi et al. (1993)
proposed that the “particle-accumulating layer” between the
cell wall and the capsule represented capsule precursors.
Our laboratory has shown that both -1,3 glucan and pro-
teins are required for capsule association with the cell wall
(Reese and Doering, 2003, and A. J. Reese and T. L. Doering,
unpublished results). Thus, an alternate model is that the
observed particles are proteinaceous and are involved in
linking the capsule and -1,3-glucan or perhaps in the as-
sembly of capsule fibers.
Mutation of the gene encoding a C. neoformans homolog of
the Sec4/Rab8 GTPases, SAV1, yielded a mutant that accu-
mulates exocytic vesicles. Interestingly, this gene does not
itself complement the S. cerevisiae sec4-8 mutant (Supple-
mentary Figure S1). This is the second reported fungal Sec4p
that is unable to complement sec4-8, the first being one of the
two Sec4p homologues present in Aspergillus niger (SrgAp,
Figure 2; Punt et al., 2001).
We observed another interesting difference between S.
cerevisiae and C. neoformans when C. neoformans cells were
treated with LatB, which compromises vesicle polarization
in both species by depolymerization of F-actin (Karpova et
al., 2000; Figure 7 and Supplementary Figure S5). It has been
reported that disassembly of F-actin by LatA caused vesicle
accumulation in wild-type S. cerevisiae, although secretion
per se was not blocked (Karpova et al., 2000). In contrast,
total vesicle numbers in C. neoformans treated with LatB
were slightly lower than control, whether in SAV1 or sav1
strains (Figure 7).
These differences between C. neoformans and S. cerevisiae
are noteworthy, particularly because exocytosis in C. neofor-
mans has not been specifically addressed before this work.
One earlier study did suggest that the C. neoformans Cap59
protein is involved in trafficking of capsule and of proteins
(Garcia-Rivera et al., 2004). In our studies of cap59 cells, we
have not observed specific accumulation of secretory vesi-
cles or other structures containing capsule material (A.
Yoneda and T. L. Doering, unpublished results), or any
defect in protein secretion (Supplementary Figure S3). It is
possible that Cap59p, given its weak homology to glycosyl-
transferases, is involved in GXM synthesis itself.
C. neoformans constitutively produces capsule in labora-
tory media, but this structure enlarges when cells are grown
under conditions that mimic in vivo growth, such as low
iron or 5% CO2 (Granger et al., 1985; Vartivarian et al., 1993;
Zaragoza et al., 2003). It has been assumed that these “in-
ducing” conditions cause the cell to up-regulate capsule
synthesis. However, the presence of larger capsules could
also reflect upregulation of secretion or assembly of extra-
cellular capsule polymers that have already been synthe-
sized, down-regulation of capsule degradation or release, or
production of longer polymers. Further investigation is
needed to establish the underlying mechanism of capsule
induction.
Although capsule is known to be shed from living cells,
the mechanism and rate of release have not been character-
ized. For this reason quantifying shed GXM would not
distinguish altered capsule secretion from changed levels of
GXM release from the existing capsule. It would add to our
understanding of capsule export if quantification of newly
synthesized extracellular GXM were possible. However,
there is no procedure available to completely remove pre-
existing capsule while maintaining cell viability (Gates et al.,
2004; Bryan et al., 2005). Our electron micrographs do show
extracellular capsule on the surface of sav1 cells (Figure 8).
This may be due to either the continued presence of capsule
materials that were secreted before the temperature shift or
the incomplete nature of the secretion block (Figure 4).
We have established the site of GXM synthesis and its
manner of export. Despite these advances, however, many
unanswered questions of cryptococcal capsule biosynthesis
remain. These include the mechanisms of translocation of
capsular materials across the cell wall after secretion, assem-
bly of capsule fibrils, attachment of capsule to the cell wall,
enlargement of the capsule structure upon environmental
stimuli, and shedding of capsule into the extracellular mi-
lieu. In addition to these events downstream of export, we
have not yet defined the initial stages of capsule biosynthe-
sis, including the nature of any primer molecules and of the
intracellular forms of GXM. Future studies, potentially em-
ploying the sav1 strain, should shed light on these puzzles of
cryptococcal capsule biogenesis.
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